General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Menarini(MODEST), Boston Scientific(MODEST), Bristol Myers Squibb(MODEST), Medtronic(MODEST), Bayer(SIGNIFICANT), Sanofi Aventis(MODEST), Incarda Therapeutics(MODEST), Boehringer Ingelheim(SIGNIFICANT), Richmond Pharmacology(SIGNIFICANT), Milestone(SIGNIFICANT), Abbott Laboratories(MODEST), GlaxoSmithKline(MODEST), Acesion(MODEST), Daiichi Sankyo(MODEST), Pfizer(MODEST), ARCA biopharma, Inc.(MODEST), Astellas Pharma US(MODEST), Johnson & Johnson(MODEST)

View Full Disclosure